Iveric Bio (ISEE) PT Raised to $30 at Cowen; Zimura Has Solid Profile in Likely $4B+ Market
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
Go back to Iveric Bio (ISEE) PT Raised to $30 at Cowen; Zimura Has Solid Profile in Likely $4B+ Market
September 6, 2022 6:00 AM EDT
- Primary Endpoint Met with 14.3% Reduction (p-value = 0.0064) in Mean Rate of Growth (Slope) in GA Area Over 12 Months Using Square Root Transformation; 17.7% Reduction (p-value = 0.0039) Using Observed GA Area -
- Statistically Significant Result with Favorable Safety Profile -
- Post-hoc Analysis of U.S. Patients: 25.5% Reduction (p-value = 0.0037) Using Square Root Transformation; 32.0% Reduction (p-value = 0.0033) Using Observed GA Area -
- Plan to Submit New Drug Application to the FDA by the End of the First Quarter 2023 -
-... More
September 2, 2022 8:00 AM EDT
PARSIPPANY, N.J.--(BUSINESS WIRE)--
IVERIC bio, Inc. (NASDAQ: ISEE) today reported that on September 1, 2022, the Company granted equity-based awards pursuant to the Companys 2019 Inducement Stock Incentive Plan to two newly-hired, non-executive employees. These inducement grants were approved by the Companys compensation and talent strategy committee pursuant to a... More
